Compare
Compare archived captures
This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.
Descriptive changes only
This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.
Need to cite this comparison? See /cite.
Earlier capture
Drug Products - Canada.ca
Apr 18, 2025
legacy-hc-2025-04-21
ID 145841
updated3 sections changed
3 sections changed0 added0 removed+15 / -13 linesChange ratio: 5%
--- +++ @@ -1,14 +1,26 @@ Drug Products Current Consultations 2025+Consultation: Draft guidance on terms and conditions for human and veterinary drugs+[2025-12-12 - 2026-02-10]+Consultation: Draft guidance on human and veterinary drug submissions based on promising evidence and terms and conditions+[2025-12-12 - 2026-02-10]+Release of draft (step 2) ICH Guideline Q3E: Impurities: Guideline for extractables and leachables+[2025-10-17]+Consultation: Draft guidance on the plain language labelling regulations for prescription drugs+[2025-09-25]+Consultation: Adding melatonin for sleep-related use in the pediatric population to the Prescription Drug List+[2025-09-16]+Consultation: Classification of topical products containing human-derived exosomes, human extracellular vesicles, and/or human cell-conditioned media+[2025-08-14 – 2025-10-28]+Notice: Classification of topical products containing human-derived exosomes, human extracellular vesicles, and/or human cell-conditioned media+[2025-08-14] Notice of consultation: Removing carisoprodol from the Prescription Drug List (PDL) [2025-02-18] Notice of Consultation on the Prescription Drug List (PDL): Nicotine Buccal Pouches [2025-02-13] Notice of Consultation on the Prescription Drug List (PDL): Nicotine Tablets [2025-02-13]-Notice to Stakeholders – Consultation on the Impacts of Implementation of ICH M13A: Bioequivalence for Immediate Release Solid Oral Dosage Forms-[2025-01-17] 2024 Consultation: Release of Draft (Step 2) ICH guideline, ICH M15 and E6(R3) Annex 2 [2024-12-20]@@ -192,17 +204,8 @@ [2015-06-26] Consultation - Prescription Drug List (PDL): Polymyxin B [2015-06-19]-Consultation - New Labelling Standard (Oral Adult Decongestant)-[2015-06-01] Notice: Health Canada and United States Food and Drug Administration Joint Public Consultation on International Conference on Harmonisation Guidelines for Registration of Pharmaceuticals for Human Use [2015-04-10]-Protecting Canadians from Unsafe Drugs Act-Transparency Needs-based Assessment-[2015-03-25]-Consultation on the Amendments to the-Food and Drugs Act-: Guide to New Authorities (power to require & disclose information, power to order a label change and power to order a recall)-[2015-03-25] Consultation - Release of Draft (Step 2) International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals for Human Use Guidance: M8 - Electronic Common Technical Document: Implementation Guide [2015-03-16] 2014@@ -255,5 +258,4 @@ Scientific/Expert Advisory Committees Scientific/Expert Advisory Panels Page details-Date modified:-2025-02-18+2025-07-03